179 related articles for article (PubMed ID: 38092485)
1. Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia.
Antić Ž; Lentes J; Bergmann AK
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101511. PubMed ID: 38092485
[TBL] [Abstract][Full Text] [Related]
2. BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.
Boer JM; den Boer ML
Eur J Cancer; 2017 Sep; 82():203-218. PubMed ID: 28709134
[TBL] [Abstract][Full Text] [Related]
3. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.
Den Boer ML; van Slegtenhorst M; De Menezes RX; Cheok MH; Buijs-Gladdines JG; Peters ST; Van Zutven LJ; Beverloo HB; Van der Spek PJ; Escherich G; Horstmann MA; Janka-Schaub GE; Kamps WA; Evans WE; Pieters R
Lancet Oncol; 2009 Feb; 10(2):125-34. PubMed ID: 19138562
[TBL] [Abstract][Full Text] [Related]
4. Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia.
Tardif M; Souza A; Krajinovic M; Bittencourt H; Tran TH
Expert Opin Pharmacother; 2021 Oct; 22(14):1871-1887. PubMed ID: 34011251
[No Abstract] [Full Text] [Related]
5. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
Tran TH; Hunger SP
Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
[TBL] [Abstract][Full Text] [Related]
6. From genomics to targeted treatment in haematological malignancies: a focus on acute myeloid leukaemia.
Jakobsen NA; Vyas P
Clin Med (Lond); 2018 Apr; 18(Suppl 2):s47-s53. PubMed ID: 29700093
[TBL] [Abstract][Full Text] [Related]
7. Induction Chemotherapy Response in Childhood Acute Lymphoblastic Leukaemia and its Correlation with Cytogenetic and Molecular Features.
Rana NA; Mahmood A; Robert HM; Zahir S; Ali I; Riaz S
J Coll Physicians Surg Pak; 2022 Nov; 32(11):1430-1434. PubMed ID: 36377010
[TBL] [Abstract][Full Text] [Related]
8. B-cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification.
Yeung DTO; Osborn MP; White DL
Br J Haematol; 2022 Apr; 197(1):13-27. PubMed ID: 34747016
[TBL] [Abstract][Full Text] [Related]
9. Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like-Recent Progress in Treatment.
Kaczmarska A; Śliwa P; Zawitkowska J; Lejman M
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203891
[TBL] [Abstract][Full Text] [Related]
10. Targeting Kinase-activating Genetic Lesions to Improve Therapy of Pediatric Acute Lymphoblastic Leukemia.
Franca R; Kuzelicki NK; Sorio C; Toffoletti E; Montecchini O; Poropat A; Rabusin M; Curci D; Paladin D; Stocco G; Decorti G
Curr Med Chem; 2018; 25(24):2811-2825. PubMed ID: 28748759
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in pediatric lymphoblastic leukemia.
Kato M
Int J Hematol; 2023 Feb; 117(2):155-161. PubMed ID: 36456860
[TBL] [Abstract][Full Text] [Related]
12. [Treatment strategy for Philadelphia chromosome-positive acute lymphoblastic leukemia in children].
Shimada H
Rinsho Ketsueki; 2022; 63(7):799-804. PubMed ID: 35922951
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
Huang YH; Wan CL; Dai HP; Xue SL
Ann Hematol; 2023 Aug; 102(8):2001-2013. PubMed ID: 37227492
[TBL] [Abstract][Full Text] [Related]
14. Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence.
Bleckmann K; Schrappe M
Br J Haematol; 2016 Mar; 172(6):855-69. PubMed ID: 26773444
[TBL] [Abstract][Full Text] [Related]
15. A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript.
Mroczkowska A; Jaźwiec B; Urbańska-Rakus J; Szymanowska S; Tessmann A; Pająk S; Machnik K; Haus O; Wróbel T
BMC Med Genomics; 2022 Feb; 15(1):20. PubMed ID: 35123463
[TBL] [Abstract][Full Text] [Related]
16. [Pediatric acute lymphoblastic leukemia: update on pathophysiology and management].
Kato M
Rinsho Ketsueki; 2018; 59(5):504-510. PubMed ID: 29877240
[TBL] [Abstract][Full Text] [Related]
17. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
18. Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past.
Short NJ; Kantarjian H
Lancet Haematol; 2023 May; 10(5):e382-e388. PubMed ID: 37003279
[TBL] [Abstract][Full Text] [Related]
19. Treatment of adult acute lymphoblastic leukemia.
Gökbuget N; Hoelzer D
Hematology Am Soc Hematol Educ Program; 2006; ():133-41. PubMed ID: 17124052
[TBL] [Abstract][Full Text] [Related]
20. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside?
Izraeli S
Br J Haematol; 2010 Oct; 151(2):119-31. PubMed ID: 20678159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]